These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone. Farlay D, Boivin G, Panczer G, Lalande A, Meunier PJ. J Bone Miner Res; 2005 Sep; 20(9):1569-78. PubMed ID: 16059629 [Abstract] [Full Text] [Related]
8. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats. Ammann P, Shen V, Robin B, Mauras Y, Bonjour JP, Rizzoli R. J Bone Miner Res; 2004 Dec; 19(12):2012-20. PubMed ID: 15537445 [Abstract] [Full Text] [Related]
9. Strontium as therapy for osteoporosis. Marie PJ. Curr Opin Pharmacol; 2005 Dec; 5(6):633-6. PubMed ID: 16183330 [Abstract] [Full Text] [Related]
11. [Strontium ranelate's (Osseor) dual mode of action: increasing bone mass and decreasing bone resorption]. Kaliterna DM. Reumatizam; 2008 Dec; 55(2):73-4. PubMed ID: 19024281 [Abstract] [Full Text] [Related]
12. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages. Ortolani S, Vai S. Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319 [Abstract] [Full Text] [Related]
14. Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide. Anastasilakis AD, Polyzos SA, Avramidis A, Papatheodorou A, Terpos E. Horm Metab Res; 2009 Jul; 41(7):559-62. PubMed ID: 19204890 [Abstract] [Full Text] [Related]
15. [Strontium Ranelate as a new therapeutic agent for osteoporosis]. Imanishi Y, Nishizawa Y. Clin Calcium; 2005 Jan; 15(1):25-8. PubMed ID: 15632469 [Abstract] [Full Text] [Related]
16. Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing. Habermann B, Kafchitsas K, Olender G, Augat P, Kurth A. Calcif Tissue Int; 2010 Jan; 86(1):82-9. PubMed ID: 19960189 [Abstract] [Full Text] [Related]
17. Strontium ranelate in osteoporosis and beyond: identifying molecular targets in bone cell biology. Marie PJ. Mol Interv; 2010 Oct; 10(5):305-12. PubMed ID: 21045244 [Abstract] [Full Text] [Related]
18. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis. Adami S. Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247 [Abstract] [Full Text] [Related]
19. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bonnelye E, Chabadel A, Saltel F, Jurdic P. Bone; 2008 Jan; 42(1):129-38. PubMed ID: 17945546 [Abstract] [Full Text] [Related]
20. Addressing and meeting the needs of osteoporotic patients with strontium ranelate: a review. Boonen S. Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S21-7. PubMed ID: 16735842 [Abstract] [Full Text] [Related] Page: [Next] [New Search]